Limitations of body mass index and body fat percentage and waist-to-hip ratio in urologic cancers [0.03%]
体质指数、体脂百分比和腰臀比在泌尿系统肿瘤中的局限性
Soyeoun Kim,Jose Carlo R Elises,Tran Trong Huan et al.
Soyeoun Kim et al.
Background and objective: Body mass index (BMI) does not distinguish between adipose and lean mass or capture central adiposity. Patients with urologic malignancies differ in age and body composition, which may influence ...
Ileal conduit vs. orthotopic ileal neobladder after radical cystectomy: Systematic review and meta-analysis of long-term renal function [0.03%]
原位回肠新膀胱与输尿管皮肤造口的长期肾功能系统评价和meta分析
Tarek Mohamed,Hamza Mohamed,Mohammad Ghassab Deameh et al.
Tarek Mohamed et al.
Radical cystectomy (RC) with urinary diversion is the gold-standard treatment for muscle-invasive and BCG-resistant non-muscle-invasive bladder cancer. The 2 most common diversion techniques are the incontinent ileal conduit (IC) and the co...
Optimizing testicular cancer therapy: Survivorship perspectives on reducing late toxicities without compromising outcomes [0.03%]
优化睾丸癌治疗:从幸存者角度出发,在不降低疗效的同时减少晚期毒性反应
Kai Wen Cheng,Jersey-Kate Castillo,Antoin Douglawi et al.
Kai Wen Cheng et al.
Testicular cancer is the most common malignancy in young men with excellent survival rates. However, this success is associated with significant treatment-related toxicities. This review explores the current landscape of testicular cancer m...
Comparison of partial nephrectomy to radical nephrectomy for non-metastatic cT2 renal tumors: Results from a Canadian Multi-Institutional Collaborative [0.03%]
对非转移性cT2期肾肿瘤行部分肾切除术与根治性肾切除术的比较:来自加拿大多中心协作的结果报告
Rahul K Bansal,Raees Cassim,Ranjeeta Mallick et al.
Rahul K Bansal et al.
Background and objective: Reported outcomes of partial nephrectomy (PN) for cT2 renal cell carcinoma (RCC) have been variable. We aimed to examine outcomes of PN, compared to radical nephrectomy (RN) for cT2 RCC. ...
Effect of marital status on years of life lost from metastatic bladder cancer according to sex and race/ethnicity [0.03%]
婚姻状况对性别和种族/族裔的转移性膀胱癌患者寿命年损失的影响
Michele Petix,Federico Polverino,Leonardo Quarta et al.
Michele Petix et al.
Introduction: It is unknown whether marital status affects years of life lost (YLL) in metastatic urothelial carcinoma of the urinary bladder (mUCUB), according to sex and race/ethnicity. ...
Artificial intelligence in prostate cancer imaging: A mini-review of current applications and future directions [0.03%]
前列腺癌影像学中的人工智能:当前应用和未来方向的简短综述
Mehmet Ali Ergül,Volkan Sabur
Mehmet Ali Ergül
This mini-review synthesizes evidence from recent studies to provide an updated perspective on current applications, methodological challenges, and future directions for artificial intelligence (AI) in multiparametric magnetic resonance ima...
Mixture cure model analysis of event-free survival in the NIAGARA Trial: Quantifying the cure fraction benefit of perioperative durvalumab in muscle-invasive bladder cancer [0.03%]
NIAGARA试验事件无复发生存的混合治愈模型分析:在肌层浸润性膀胱癌中定量 perioperative durvalumab 的治愈率收益
Shugo Yajima,Soichiro Yoshida,Wei Chen et al.
Shugo Yajima et al.
Introduction: The NIAGARA trial demonstrated improved event-free survival (EFS) with perioperative durvalumab plus gemcitabine-cisplatin (GC) vs. GC alone in muscle-invasive bladder cancer (MIBC). This analysis applied mi...
Nectin-4 drives aggressive tumor biology and poor prognosis in renal cell carcinoma [0.03%]
Nectin-4驱动肾细胞癌的侵袭性肿瘤生物学和不良预后
Tomoya Hatayama,Yohei Sekino,Takashi Babasaki et al.
Tomoya Hatayama et al.
Nectin‑4, a cell adhesion molecule and emerging therapeutic target in several malignancies, has not been fully characterized in renal cell carcinoma (RCC). This study aimed to define the clinical significance, biological function, and ther...
Collecting electronic patient-reported outcomes via smartphone text messages in a bladder cancer RCT: A feasibility study [0.03%]
利用智能手机短信收集电子患者报告结果在一项膀胱癌随机对照试验中的可行性研究
Lene Munk,Vanaja Kumarasegaram,Josephine Maria Hyldgaard et al.
Lene Munk et al.
Patient-reported outcome measures are increasingly used to assess symptoms, treatment tolerance, and quality of life (QoL) in oncology. Electronic patient-reported outcome measures (ePROM) offer advantages over paper questionnaires, but lar...